An interventional study of Think and Regulate Affective State Task in Bipolar Disorder I or II and Healthy (Controls), sponsored by Laureate Institute for Brain Research, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-17.
Sponsored by Laureate Institute for Brain Research, Inc. · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 836 studies in Bipolar Disorder with a site in United States — 77 open to participants now, 96 under way, 8 of them phase 3. Bipolar Disorder · United States.
Among the 836 studies in Bipolar Disorder with a site in United States, this one is the 287th largest by planned enrollment of the 703 interventional ones that give a count, is one of 25 that started in 2025, is one of 276 with no phase, reaches primary completion later than 70 of the 94 other live ones, and was the 821st registered.
1,686 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →77 of the 836 studies in Bipolar Disorder with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 18–80
Icahn School of Medicine at Mount Sinai · Sites in United States
Ages 22–70
Massachusetts General Hospital · Sites in United States
Ages 18–65
Massachusetts General Hospital · Sites in United States
Ages 18–65
AbbVie · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
836 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 56 · Phase 2 119 · Phase 3 129 · Phase 4 155
First in 1979; this study’s year is marked. 25 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 72 is above the median of 64 across 1,282 interventional studies indexed under Bipolar Disorder.
Median enrollment 58 across the 703 interventional studies, 107 across the 128 observational. Of the 695 that completed or were terminated, 305 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
148 of 836 have an industry lead sponsor. The 10 most frequent:
Laureate Institute for Brain Research, Inc. is the lead sponsor of 54 studies on the registry; 11 are open to participants now.
Laureate Institute for Brain Research, Inc. has 4 studies filed under Bipolar Disorder — fewer than ten, so there is no comparison to draw.
37 of the studies in Bipolar Disorder with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07140913Phase 3Bristol-Myers SquibbA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine | 2027-06-28 |
| NCT05457127University of California, San DiegoObstructive Sleep Apnea Treatment in Serious Mental Illness | 2026-11 |
| NCT03573349Mayo ClinicKetamine Associated ACC GABA and Glutamate Change and Depression Remission: | 2026-12 |
| NCT03349528Sheppard Pratt Health SystemProbiotics to Prevent Relapse After Hospitalization for Bipolar Depression | 2026-12 |
| NCT06226025Leslie SwansonCorrecting Circadian Rhythms to Breakthrough in Bipolar Disorder | 2026-12 |
Add all 37 to your calendar (.ics) → With an account.
Among the 836 studies in Bipolar Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this neuroimaging study is to investigate how emotional states fluctuate in people with bipolar disorder (BD) compared to healthy controls, and to understand the neural mechanisms driving mood instability. The main questions it aims to answer are:
Researchers will compare individuals with bipolar disorder (BD-I or BD-II, currently depressed or mixed state) to healthy controls without psychiatric history to see whether the BD group shows greater fluctuations in emotional brain activity and whether positive emotion regulation strategies normalize this instability.
Participants will:
This research will help clarify how the brain supports or disrupts emotional regulation in bipolar disorder and may inform the development of personalized, neurobiologically informed treatments for mood instability.
This neuroimaging study investigates the neural mechanisms underlying emotional dynamics and mood instability in individuals with bipolar disorder (BD). Bipolar disorder is characterized by rapid and intense mood fluctuations, yet the neurobiological basis of these transitions, how the brain shifts between emotional states in real time, remains poorly understood. The study aims to identify the moment-to-moment brain processes that drive emotional lability and to explore whether positive emotion amplification can stabilize emotional and neural states in BD.
Study Design
This is a study conducted at the Laureate Institute for Brain Research (LIBR) in Tulsa, Oklahoma. The study includes 72 participants total: 36 adults diagnosed with bipolar disorder type I or II (currently in a depressive or mixed state) and 36 healthy control participants without psychiatric history. Participants will complete two visits:
Data will be collected using multimodal methods, including functional magnetic resonance imaging (fMRI), diffusion weighted imaging (DWI), structural MRI, and physiological monitoring (heart rate, respiration). Behavioral and emotional measures will be recorded throughout the study to align neural data with subjective emotional experience.
Scientific Rationale Mood instability is a defining and impairing feature of bipolar disorder, associated with deficits in emotion regulation and cognitive control. Prior neuroimaging work has identified alterations in prefrontal-limbic circuitry, including decreased activation in regulatory regions such as the anterior cingulate cortex (ACC) and prefrontal cortex (PFC), and increased activation in emotion-responsive regions such as the amygdala. However, most studies examine static mood states rather than dynamic fluctuations in emotional experience.
The present study applies machine learning, complexity science, and network control theory to quantify and model emotional state dynamics. By decoding brain activity during emotion regulation tasks, the research aims to characterize how emotional states evolve over time, how this differs in BD compared to healthy controls, and whether targeted regulation strategies, specifically positive emotion amplification, can modulate these dynamics.
Specific Aims and Hypotheses Aim 1: Decode momentary emotional states from whole-brain fMRI data using machine learning approaches.
Hypothesis 1: A machine learning classifier can accurately distinguish distinct emotional states (e.g., rumination vs. positive reflection) from fMRI activation patterns. BD participants will exhibit more unstable, fluctuating state trajectories than healthy controls.
Aim 2: Quantify emotional dynamics using metrics from complexity science and network control theory.
Hypothesis 2: Individuals with BD will show higher emotional metastability and lower fractal scaling-indicators of greater temporal irregularity in brain activity-relative to healthy controls. Network control theory analysis will identify the brain regions that contribute to state transitions.
Aim 3: Examine the effects of positive emotion amplification on emotional stability and brain network dynamics.
Hypothesis 3: The regulation of positive affect will engage cognitive control regions (e.g., dorsolateral PFC, ACC) and promote more stable emotional trajectories in BD participants.
Experimental Tasks and Procedures
Participants will undergo informed consent, psychiatric screening (using the MINI), and a series of standardized questionnaires assessing mood, emotion regulation, anxiety, rumination, and hedonic capacity (e.g., MADRS, YMRS, PANAS-X, DERS, ERQ, STAI, PROMIS scales).
Participants will also recall eight autobiographical events-four positive (reminiscence) and four negative (rumination)-and write brief keyword descriptions of each. These personalized cues will be used later in the MRI task to elicit emotional states without revealing personal content.
Participants will complete both resting-state and task-based MRI scans lasting up to two hours. Physiological signals (heart rate and respiration) will be recorded concurrently to remove physiological artifacts and examine autonomic correlates of emotion.
MRI sequences include:
TReAT Task Overview
The Think and Regulate Affective States Task (TReAT) is a novel paradigm designed to model real-world emotional processing. Participants are presented with brief cue words corresponding to their personal autobiographical events and alternate between several types of blocks:
These blocks are repeated across four fMRI runs, each lasting approximately 12-15 minutes. The design allows modeling of both spontaneous and regulated emotional states, enabling fine-grained temporal decoding of emotional dynamics.
After each run, participants rate fatigue, sleepiness, and emotional engagement. Post-scan questionnaires (e.g., PANAS-X, STAI-S, Feedback Questionnaire) assess emotional and physical comfort.
Data Analysis Plan Functional MRI data will be preprocessed using standard pipelines and analyzed with multivariate pattern analysis (MVPA) to classify emotional states. State-space trajectory analyses will examine how decoded brain states fluctuate over time within and between subjects. Measures of metastability, fractal scaling, and network controllability will quantify the temporal complexity and flexibility of brain networks.
Between-group comparisons (BD vs. HC) will assess whether BD participants exhibit greater temporal irregularity or reduced control energy in emotion-related circuits. The modulation of these parameters by positive emotion regulation will be tested using within-subject contrasts of Regulation vs. Think blocks.
Scientific and Clinical Significance This study integrates cutting-edge computational methods: machine learning, complexity metrics, and network control theory to decode the temporal structure of emotion regulation in bipolar disorder. By identifying neurobiological signatures of instability and testing whether positive affect regulation stabilizes these dynamics, this work aims to bridge the gap between affective neuroscience and personalized psychiatry.
The resulting dataset will contribute to the National Institute of Mental Health (NIMH) Data Archive and inform future large-scale studies targeting biomarkers of emotional dysregulation. Ultimately, this research will lay the groundwork for adaptive, brain-state-driven treatments that dynamically respond to patients' emotional states, offering new strategies for mood stabilization in bipolar disorder.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Able to provide
BD Group:
Moderate or greater depressive symptom severity (MADRS ≥ 15 or PHQ-9 ≥ 10)
HC Group:
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants complete the same two-session protocol: a preparation visit with diagnostic interviews and questionnaires, followed by an MRI session including resting-state and task-based scans. During the Think and Regulate Affective States Task (TReAT), participants recall personal positive and negative memories, rate their emotions, and practice positive emotion amplification strategies. Physiological signals are recorded throughout. Both individuals with bipolar disorder and healthy controls complete identical procedures for comparison of brain and emotional dynamics.
Behavioral: Think and Regulate Affective State Task
Participants complete the Think and Regulate Affective States Task (TReAT) during fMRI scanning. This task presents brief cues of participants' own autobiographical memories, four positive and four negative, to evoke corresponding emotional states. While viewing these cues, participants alternate between thinking about the memory, rating emotional valence and arousal, and practicing positive emotion amplification strategies. Each session includes multiple blocks of "Think," "Rate," "Regulate," "Attention," and "Rest" periods. Physiological measures (heart rate and respiration) are recorded concurrently. The task is designed to decode emotional states from fMRI data and evaluate the neural impact of positive emotion regulation in bipolar disorder compared to healthy controls.
Decoded Emotional State Trajectory
The decoded emotional state time course derived from fMRI during the Think and Regulate Affective States Task (TReAT). Temporal irregularity will be quantified using permutation entropy to assess emotional state instability in individuals with bipolar disorder compared to healthy controls.
Time frame: Day 2
Metastability of brain network states
Metastability of brain network states will be calculated from whole-brain fMRI data to characterize variability in emotional states.
Time frame: Day 2
Brain regional contributions to the transition energy of emotional brain state changes
Brain regional contributions to the transition energy of emotional brain state changes, derived from network control theory, will be calculated to identify regions that drive transitions between emotional states.
Time frame: Day 2
Fractal scaling of brain state changes
Fractal scaling of brain state changes will be calculated from whole-brain fMRI data to characterize the regularity of emotional brain states.
Time frame: Day 2
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified individual participant data (IPD) from this study may be shared through public research repositories such as the National Institute of Mental Health (NIMH) Data Archive (NDA) following study completion. Shared data may include de-identified participant demographics, behavioral and questionnaire responses, functional and structural neuroimaging data, and study participation details. Data will be stripped of all identifying information in compliance with HIPAA and institutional standards for de-identification. To enable data sharing, information required to generate a Global Unique Identifier (GUID) will be collected according to NDA specifications. All data will be stored securely on encrypted servers and retained for at least three years after study completion, in accordance with federal and institutional requirements. Study findings will be disseminated through peer-reviewed journal publications, scientific conferences, and public data repositories.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Access criteria: Qualified researchers with approved data use agreements may request access through the National Institute of Mental Health (NIMH) Data Archive (NDA). Access requires institutional affiliation, completion of the NDA Data Use Certification process, and agreement to comply with all confidentiality, security, and ethical use requirements. Data will be shared only in de-identified form through the NDA's secure access system; no direct identifiers or contact information will be provided.
Started Oct 2025 (actual). Primary completion is estimated for Nov 2028, 37 months after the start.
Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 37 months is close to that.
Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Laureate Institute for Brain Research, Inc.